US advisers endorse single-shot COVID-19 vaccine from J&J
WASHINGTON — U.S. health advisers have endorsed a one-dose COVID-19 vaccine from Johnson & Johnson that’s expected to provide an easier-to-use option to fight the pandemic.
The panel of Food and Drug Administration experts ruled on Friday that J&J’s vaccine protected against COVID-19 and should be made available for adults.
The FDA is expected to quickly follow the recommendation and make J&J’s shot the third vaccine authorized for emergency use in the U.S. Shipments of a few million doses could begin as early as Monday.
More shots are urgently needed to stay ahead of a mutating virus that has killed more than 500,000 Americans.
COPYRIGHT 2021 THE ASSOCIATED PRESS. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED.